Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Sergey Glinyanov from Loop Capital Markets issued a price target of $4.50 for SATL on 2026-03-11 14:16:00.The adjusted price target was set to $4.50.At the time of the announcement,...
March 11, 2026 SATL -1.37%
Eddie Hickman from Guggenheim issued a price target of $23.00 for ZVRA on 2026-03-10 10:40:00.The adjusted price target was set to $23.00.At the time of the announcement, ZVRA...
March 10, 2026 ZVRA -7.19%
from GLJ Research issued a price target of $17.00 for ONDS on 2026-03-10 10:16:00.The adjusted price target was set to $17.00.At the time of the announcement, ONDS...
March 10, 2026 ONDS -4.65%
from H.C. Wainwright issued a price target of $17.00 for ONDS on 2026-03-10 10:16:00.The adjusted price target was set to $17.00.At the time of the announcement, ONDS...
March 10, 2026 ONDS -4.65%
Mark Hughes from Truist Financial issued a price target of $39.00 for HRTG on 2026-03-09 19:58:00.The adjusted price target was set to $39.00.At the time of the announcement,
March 9, 2026 HRTG -0.19%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| CVGI Commercial Vehicle Group, | 2.11
30.44% | ||||||||||||||||||
| OCGN Ocugen, Inc. | 2.28
28.53% | ||||||||||||||||||
| ADAG Adagene Inc. | 3.70
26.11% | ||||||||||||||||||
| ATPC Agape ATP Corporation | 4.42
16.93% | ||||||||||||||||||
| CARM Carisma Therapeutics, Inc | 0.04
15.73% | ||||||||||||||||||
| APYX Apyx Medical Corporation | 3.96
14.78% | ||||||||||||||||||
| SERA Sera Prognostics, Inc. | 2.08
13.66% | ||||||||||||||||||
| ARQQW Arqit Quantum Inc. Warran | 0.15
13.56% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 2.89%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -1.90%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -2.71%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -1.28%